Published in Eur Arch Psychiatry Clin Neurosci on February 17, 2009
The cholinergic hypothesis of cognitive aging revisited again: cholinergic functional compensation. Pharmacol Biochem Behav (2011) 1.07
Mild cognitive impairment in older adults. Curr Psychiatry Rep (2012) 0.78
Major depressive disorder in older adults: benefits and hazards of prolonged treatment. Drugs Aging (2014) 0.76
What was new, interesting and frequently cited in 2009? Eur Arch Psychiatry Clin Neurosci (2010) 0.75
Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials (1996) 64.38
Mild cognitive impairment: clinical characterization and outcome. Arch Neurol (1999) 33.06
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol (2007) 18.62
Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med (2005) 12.04
Forecasting the global burden of Alzheimer's disease. Alzheimers Dement (2007) 10.01
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol (2006) 9.99
A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group. Neurology (1998) 7.27
Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial. BMJ (1999) 5.36
Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci U S A (2006) 5.00
Intranasal insulin improves cognition and modulates beta-amyloid in early AD. Neurology (2007) 4.14
Classification criteria for mild cognitive impairment: a population-based validation study. Neurology (2001) 3.92
MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment. Neurology (2007) 3.24
Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study. Lancet Neurol (2007) 3.22
The GSK3 hypothesis of Alzheimer's disease. J Neurochem (2007) 3.16
A multinational, randomised, 12-week, comparative study of donepezil and rivastigmine in patients with mild to moderate Alzheimer's disease. Int J Clin Pract (2002) 2.86
Safety and efficacy of galantamine in subjects with mild cognitive impairment. Neurology (2008) 2.79
Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science (1992) 2.50
Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor. Proc Natl Acad Sci U S A (1992) 2.31
Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis. CMAJ (2003) 2.18
Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment. Neurology (2004) 2.00
Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial. Neurology (2004) 1.91
Disease-modifying therapies for Alzheimer disease: challenges to early intervention. Neurology (2007) 1.88
Stability of the preclinical episodic memory deficit in Alzheimer's disease. Brain (2001) 1.83
An estimate of the total worldwide societal costs of dementia in 2005. Alzheimers Dement (2007) 1.83
Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease? Am J Psychiatry (2005) 1.71
Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease. Arch Neurol (2001) 1.62
Endpoints for trials in Alzheimer's disease: a European task force consensus. Lancet Neurol (2008) 1.51
Cholinergic enhancement of frontal lobe activity in mild cognitive impairment. Brain (2004) 1.44
Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer's disease? J Neurol Neurosurg Psychiatry (2005) 1.21
Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature. World J Biol Psychiatry (2008) 1.17
Long-term efficacy and safety of galantamine in patients with mild-to-moderate Alzheimer's disease: multicenter trial. Eur J Neurol (2004) 1.15
Increase of BDNF serum concentration during donepezil treatment of patients with early Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci (2007) 1.11
Cognitive performance in Alzheimer's disease patients receiving rivastigmine for up to 5 years. Int J Clin Pract (2005) 1.04
Muscarinic regulation of Alzheimer's disease amyloid precursor protein secretion and amyloid beta-protein production in human neuronal NT2N cells. J Biol Chem (1995) 1.00
Effects of galantamine on working memory and global functioning in patients with mild cognitive impairment: a double-blind placebo-controlled study. Am J Alzheimers Dis Other Demen (2005) 0.97
Do cholinergic therapies have disease-modifying effects in Alzheimer's disease? Alzheimers Dement (2006) 0.95
Muscarinic agonists reduce tau phosphorylation in non-neuronal cells via GSK-3beta inhibition and in neurons. J Neural Transm (Vienna) (2000) 0.89
M1 muscarinic receptor activation protects neurons from beta-amyloid toxicity. A role for Wnt signaling pathway. Neurobiol Dis (2004) 0.87
Conversion. Neurology (2006) 0.86
Mild cognitive impairment: a concept ready to move on? Curr Opin Psychiatry (2008) 0.82
MCI treatment trials: failure or not? Lancet Neurol (2007) 0.78
Differential efficacy of treatment with acetylcholinesterase inhibitors in patients with mild and moderate Alzheimer's disease over a 6-month period. Dement Geriatr Cogn Disord (2005) 0.77
Mental disorders in megacities: findings from the São Paulo megacity mental health survey, Brazil. PLoS One (2012) 1.56
Comparison of repetitive transcranial magnetic stimulation and electroconvulsive therapy in unipolar non-psychotic refractory depression: a randomized, single-blind study. Int J Neuropsychopharmacol (2006) 1.20
Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature. World J Biol Psychiatry (2008) 1.17
Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment. World J Biol Psychiatry (2010) 1.12
Increased serum IL-1beta level in Alzheimer's disease and mild cognitive impairment. Dement Geriatr Cogn Disord (2009) 1.10
Lithium reduces Gsk3b mRNA levels: implications for Alzheimer Disease. Eur Arch Psychiatry Clin Neurosci (2008) 1.03
The detection of depression in medical setting: a study with PRIME-MD. J Affect Disord (2006) 1.00
The use of ASB-14 in combination with CHAPS is the best for solubilization of human brain proteins for two-dimensional gel electrophoresis. Brief Funct Genomic Proteomic (2007) 0.97
Mild cognitive impairment: cognitive screening or neuropsychological assessment? Rev Bras Psiquiatr (2008) 0.97
White matter abnormalities associated with Alzheimer's disease and mild cognitive impairment: a critical review of MRI studies. Expert Rev Neurother (2013) 0.96
Profiles of functional deficits in mild cognitive impairment and dementia: benefits from objective measurement. J Int Neuropsychol Soc (2010) 0.96
Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders. Neuropsychiatr Dis Treat (2013) 0.95
Recognition of depressive symptoms by physicians. Clinics (Sao Paulo) (2009) 0.93
Clinically significant depressive symptoms and associated factors in community elderly subjects from Sao Paulo, Brazil. Am J Geriatr Psychiatry (2009) 0.91
Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression. J Psychiatr Res (2010) 0.91
Serum brain-derived neurotrophic factor level is reduced in antidepressant-free patients with late-life depression. World J Biol Psychiatry (2010) 0.91
Impact of sociodemographic and health variables on mini-mental state examination in a community-based sample of older people. Eur Arch Psychiatry Clin Neurosci (2010) 0.91
Use of psychoactive substances and sexual risk behavior in adolescents. Subst Use Misuse (2002) 0.88
Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease. J Alzheimers Dis (2010) 0.88
Physical exercise in MCI elderly promotes reduction of pro-inflammatory cytokines and improvements on cognition and BDNF peripheral levels. Curr Alzheimer Res (2014) 0.87
The more information, the more negative stigma towards schizophrenia: Brazilian general population and psychiatrists compared. Psychiatry Res (2012) 0.86
Diagnosis of mild cognitive impairment revisited after one year. Preliminary results of a prospective study. Dement Geriatr Cogn Disord (2009) 0.86
Diagnostic transitions in mild cognitive impairment subtypes. Int Psychogeriatr (2009) 0.85
Interleukin-1beta serum levels is increased in antidepressant-free elderly depressed patients. Am J Geriatr Psychiatry (2010) 0.85
Optimizing the CAMCOG test in the screening for mild cognitive impairment and incipient dementia: saving time with relevant domains. Int J Geriatr Psychiatry (2011) 0.84
31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospholipid and high-energy phosphate metabolism. Schizophr Res (2002) 0.84
Verbal fluency in the detection of mild cognitive impairment and Alzheimer's disease among Brazilian Portuguese speakers: the influence of education. Int Psychogeriatr (2009) 0.84
Vocational rehabilitation improves cognition and negative symptoms in schizophrenia. Schizophr Res (2010) 0.83
Cross-cultural adaptation, reliability and validity of the DAFS-R in a sample of Brazilian older adults. Arch Clin Neuropsychol (2010) 0.83
Aripiprazole for patients with schizophrenia and schizoaffective disorder: an open-label, randomized, study versus haloperidol. CNS Spectr (2009) 0.82
Lower phosphorylated glycogen synthase kinase-3B levels in platelets of patients with schizophrenia: increment by olanzapine treatment. Eur Arch Psychiatry Clin Neurosci (2014) 0.82
Language impairment in euthymic, elderly patients with bipolar disorder but no dementia. Int Psychogeriatr (2008) 0.81
Platelet GSK3B activity in patients with late-life depression: marker of depressive episode severity and cognitive impairment? World J Biol Psychiatry (2011) 0.81
Stigma toward schizophrenia: do all psychiatrists behave the same? Latent profile analysis of a national sample of psychiatrists in Brazil. BMC Psychiatry (2013) 0.81
SHORT COMMUNICATION: Apolipoprotein E genotype and cognition in bipolar disorder. CNS Neurosci Ther (2010) 0.80
Combining functional scales and cognitive tests in screening for mild cognitive impairment at a university-based memory clinic in Brazil. Rev Bras Psiquiatr (2008) 0.80
A preliminary controlled trial of cognitive behavioral therapy in clozapine-resistant schizophrenia. J Nerv Ment Dis (2009) 0.79
COMT Met (158) modulates facial emotion recognition in bipolar I disorder mood episodes. J Affect Disord (2012) 0.79
Relative bioavailability of two oral formulations of risperidone 2 mg: A single-dose, randomized-sequence, open-label, two-period crossover comparison in healthy Brazilian volunteers. Clin Ther (2010) 0.79
Long-term decrease in immediate early gene expression after electroconvulsive seizures. J Neural Transm (Vienna) (2012) 0.78
Psychometric characteristics of the Rivermead Behavioural Memory Test (RBMT) as an early detection instrument for dementia and mild cognitive impairment in Brazil. Int Psychogeriatr (2010) 0.78
Allelic association analysis of phospholipase A2 genes with schizophrenia. Psychiatr Genet (2004) 0.78
Cognitive-linguistic deficits in euthymic elderly patients with bipolar disorder. J Affect Disord (2013) 0.77
Functional mobility in a divided attention task in older adults with cognitive impairment. J Mot Behav (2015) 0.77
Reduced activities of phospholipases A2 in platelets of drug-naïve bipolar disorder patients. Bipolar Disord (2014) 0.77
Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease. Neuromolecular Med (2015) 0.77
Fear of falling and falls in older adults with mild cognitive impairment and Alzheimer's disease. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn (2014) 0.77
Antipsychotic drugs decrease iPLA2 gene expression in schizophrenia. Schizophr Res (2013) 0.76
The Brazilian version of the Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity in dementia. Int Psychogeriatr (2013) 0.76
Higher proportion of inactive Gsk3β in platelets of elderly patients with bipolar disorder: an effect of treatment? Rev Bras Psiquiatr (2013) 0.76
Correction: The Absence of CYP3A5*3 Is a Protective Factor to Anticonvulsants Hypersensitivity Reactions: A Case-Control Study in Brazilian Subjects. PLoS One (2015) 0.75
Formal Thought Disorder and language impairment in schizophrenia. Arq Neuropsiquiatr (2012) 0.75
Mental healthcare in South America with a focus on Brazil: past, present, and future. Curr Opin Psychiatry (2016) 0.75
Protein Expression of BACE1 is Downregulated by Donepezil in Alzheimer's Disease Platelets. J Alzheimers Dis (2016) 0.75
Glycogen Synthase Kinase-3β: Variation over Time and the Possible Association with Mood and Cognition in Healthy Individuals. Neuropsychobiology (2016) 0.75
[Biologic artifacts in quantitative EEG]. Arq Neuropsiquiatr (2006) 0.75